MaaT Pharma
Research - Lyon, Auvergne-Rhône-Alpes, France
MaaT Pharma Employees
Isabelle Adeline
Chief Of Staff - Special Projects, Regulatory, IP & QA Director
MaaT Pharma Details
MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome. MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spear-head microbiome treatment integration into clinical practice.Hervé Affagard, CEO & Co-founder
MaaT Pharma Technologies
Captcha
reCAPTCHA
Load Balancers
Apache
CMS
WordPress.org
Tag Management
Google Tag Manager
Other
Mobile Friendly
Analytics and Tracking
Hotjar